PEGFILGRASTIM for Breast cancer female: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 635 adverse event reports in the FDA FAERS database where PEGFILGRASTIM was used for Breast cancer female.
Most Reported Side Effects for PEGFILGRASTIM
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Device adhesion issue | 11,326 | 14.0% | 9 | 12 |
| Wrong technique in product usage process | 10,217 | 12.6% | 13 | 80 |
| Unintentional medical device removal | 8,882 | 11.0% | 7 | 23 |
| Device malfunction | 6,818 | 8.4% | 3 | 53 |
| Device use error | 6,001 | 7.4% | 4 | 20 |
| Device issue | 5,071 | 6.3% | 7 | 48 |
| Accidental exposure to product | 4,967 | 6.1% | 1 | 13 |
| Device occlusion | 3,239 | 4.0% | 3 | 13 |
| Off label use | 3,228 | 4.0% | 140 | 299 |
| Bone pain | 2,266 | 2.8% | 48 | 421 |
| Febrile neutropenia | 2,154 | 2.7% | 237 | 1,203 |
| Drug dose omission | 2,089 | 2.6% | 3 | 52 |
| Drug dose omission by device | 2,051 | 2.5% | 3 | 26 |
| Neutropenia | 1,863 | 2.3% | 163 | 659 |
| Intercepted product preparation error | 1,514 | 1.9% | 1 | 1 |
Other Indications for PEGFILGRASTIM
Product used for unknown indication (43,274)
Neutropenia (21,342)
Prophylaxis (7,424)
Breast cancer (813)
B-cell lymphoma (774)
Colony stimulating factor therapy (692)
Febrile neutropenia (492)
Colony stimulating factor prophylaxis (436)
Agranulocytosis (272)
Off label use (248)
Other Drugs Used for Breast cancer female
PALBOCICLIB (17,915)
DOCETAXEL (12,384)
ABEMACICLIB (3,576)
CAPECITABINE (2,576)
CYCLOPHOSPHAMIDE (2,547)
TUCATINIB (1,890)
FULVESTRANT (1,292)
EPIRUBICIN (1,236)
TRASTUZUMAB (1,068)
PACLITAXEL (887)